Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation

A technology for gestational hypertension and growth retardation, which can be used in cardiovascular system diseases, sexual diseases, medical preparations containing active ingredients, etc., and can solve problems such as difficult treatment.
CN101778635AInactive Publication Date: 2010-07-14PANTARHEI BIOSCI

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
PANTARHEI BIOSCI
Publication Date
2010-07-14
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to the use of a steroid in the manufacture of a pharmaceutical composition for use in the therapeutic or prophylactic treatment of a hypertensive disorder of pregnancy (HDP) or fetal growth retardation, said treatment comprising administering to a female mammal a steroid selected from the group consisting of: substances represented by the following formula (formula I) in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1 - 5 carbon atoms; each of R5, R6, R7 is a hydroxyl group; no more than 3 of R1, R2, R3, R4 are hydrogen atoms; precursors of such substances; and mixtures of one or more of the aforementioned substances and / or precursors.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the treatment or prevention of hypertensive disorder of pregnancy (HPD) or fetal growth retardation. Background technique

[0002] What hypertensive disorders of pregnancy and fetal growth retardation have in common is that they are both associated with inadequate blood supply via the uterine arteries. Another thing these lesions have in common is that they are currently very difficult to treat.

[0003] Examples of hypertensive disorders of pregnancy include hypertensive disorders selected from pre-eclampsia, eclampsia, HELLP syndrome, and gestational hypertension or pregnancy-induced hypertension. All of these hypertensive lesions are thought to be related to insufficient blood supply via the uterine arteries.

[0004] WO 95 / 02408 teaches the combined use of progestins and nitric oxide synthase substrates in the treatment of preeclampsia and preterm birth. It is noted from this international patent application that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More